Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling

Aging

Volumn 3, Issue 10, 2011, Pages 1028-1038

  Halicka, H Dorota ^a   Zhao, Hong ^a   Li, Jiangwei ^a   Traganos, Frank ^a   Zhang, Sufang ^a   Lee, Marietta ^a   Darzynkiewicz, Zbigniew ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

ATM activation; Cell cycle; DNA replication stress; H2AX phosphorylation; Reactive oxidant species (ROS)

Indexed keywords

EID: 80855165212     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100397     Document Type: Article

References (76)

1. Barzilai A and Yamamoto K: DNA damage responses to oxidative stress. DNA repair (Amst) 2004:3;1109-1115.
2. Nohl H. Generation of superoxide radicals as byproducts of cellular respiration. Ann Biol Clin 1994;52:199-204.
3. Moller P and Loft S. Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 2004;551:79-89.
4. Beckman KB and Ames BN. Oxidative decay of DNA. J Biol Chem 1997;272: 13300-13305.
5. Dianov GL, Parsons JL. Co-ordination of DNA single strand break repair. DNA repair (Amst) 2007;6:454-460.
6. Vilenchik MM and Knudson AG. Endogenous DNA doublestrand breaks: Production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA 2003;100:12871-12876.
7. Taioli E, Sram RJ, Garte BM, Kalina I, Popov TA and Farmer PB. Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage (EXPAH project): description of the population under study. Mutat Res 2007;620:1-6.
8. Tanaka T, Halicka HD, Traganos F and Darzynkiewicz Z. Phosphorylation of histone H2AX on Ser 139 and activation of ATM during oxidative burst in phorbol ester-treated human leukocytes. Cell Cycle 2006;5:2671-2675.
9. Shacter E, Beecham EJ, Covey JM, Kohn KW and Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 1988;9:2297-2304.
10. Chong YC, Heppner GH, Paul LA and Fulton AM. Macrophage-mediated induction of DNA strand breaks in target tumor cells. Cancer Res 1989;49:6652-6657.
11. Demirbag R, Yilmaz R, Kocyigit A and Guzel S. Effect of coronary angiography on oxidative DNA damage observed in circulating lymphocytes. Angiology 2007;58:141-147.
12. Altman SA, Zastawny TH, Randers-Eichorn L, Caciuttolo MA, Akman SA, Disdaroglu M and Rao G. Formation of DNA-protein cross-links in cultured mammalian cells upon treatment with iron ions. Free Radic Biol Med 1995;19:897-902.
13. Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL and Sauvaigo S. Hydroxyl radicals and DNA base damage. Mutat Res 1999;424:9-21.
14. Marnett LJ, Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002; 219:181-182.
15. Pastwa E and Blasiak J. Non-homologous DNA end joining. Acta Biochim Pol 2003;50:891-908.
16. Jeggo PA and Lobrich M. Artemis links ATM to double strand end rejoining. Cell Cycle 2005;4:359-362.
17. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 2011; Jan7 (Epub)
18. Gorbunova V, Seluanov A. Making ends meet in old age: DSB repair and aging. Mech Ageing Dev 2005;126:621-628.
19. Espejel S, Franco S, Rodriguez-Perales S, Bouffler SD, Cigudosa JC, Blasco MA. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J 2002;21:2207-2219.
20. Karanjawala ZE, Lieber MR. DNA damage and aging. Mech Ageing Dev 2004; 125:405-416.
21. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle 2008;7:3344-3354.
22. Blagosklonny MV, Campisi J. Cancer and aging: more puzzles, more promises? Cell Cycle 2008;7:2615-2618.
23. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle. 2009; 8:1888-1895.
24. Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: Preliminary proposal. Cell Cycle 2010;9:4788-4794.
25. Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle. 2010;9:3151-6.
26. Blagosklonny MV. Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis. Aging. 2010;2:177-182.
27. Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging 2009;1:281-288.
28. Pospelova TV, Demidenko ZN, Bukreeva EI, Gudkov VA, Blagosklonny MV. Cell Pseudo-DNA damage response in senescent cells. Cycle 2009;8:4112-4118.
29. Olive PL, Durand RE, Banath JP, Johnston PJ. Analysis of DNA damage in individual cells. Methods Cell Biol 2001;64:235-249.
30. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993;53:1945-1951.
31. Huang X, Halicka HD, Traganos F, Tanaka T, Kurose A, Darzynkiewicz Z. Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosis. Cell Prolif 2005;38:223-243.
32. Kitagawa R, Kastan MB. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol 2005;70:99-109.
33. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-5868.
34. Bartkova J, Bakkenist CJ, Rajpert-De Meyts E, Skakkebaek NE, Sehested M, Lukas J, Kastan MB, Bartek J. ATM activation in normal human tissues and testicular cancer. Cell Cycle 2005;4:838-845.
35. Sedelnikova OA, Rogakou EP, Panuytin IG, Bonner W. Quantitive detection of 125IUdr-induced DNA double-strand breaks with γ-H2AX antibody. Ratiation Res 2002;158:486-492.
36. Huang X, Traganos F, Darzynkiewicz Z. DNA damage induced by DNA topoisomerase I- and topoisomerase II- inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2003; 2:614-619.
37. Banath JP, Olive PL. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res 2003; 63:4347-4350.
38. Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP, Dai W, Darzynkiewicz Z. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 2007; 71A:648-661.
39. Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 2006;5:1940-1945.
40. Zhao H, Tanaka T, Halicka HD, Traganos F, Zarebski M, Dobrucki J, Darzynkiewicz Z. Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports the aging-related processes. Cytometry A 2007;71A:905-914.
41. Tanaka T, Kajstura M, Halicka HD, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif 2007;40:1-13.
42. Tanaka T, Kurose A, Halicka HD, Traganos F, Darzynkiewicz Z. 2-Deoxy-D-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone H2AX. Cell Cycle 2006; 5:878-882.
43. Zhao H, Tanaka T, Mitlitski V, Heeter J, Balazs EA, Darzynkiewicz Z. Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int J Oncol 2008;32:1159- 1169.
44. Halicka HD, Darzynkiewicz Z, Teodori L. Attenuation of constitutive ATM activation and H2AX phosphorylation in human leukemic TK6 cells by their exposure to static magnetic field. Cell Cycle, 2009;8:3236-3238.
45. Halicka HD, Ita M, Tanaka T, Kurose A, Darzynkiewicz Z. The biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage. Pharmacol Rep 2008;60:93-100.
46. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007;100:328- 341.
47. Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans 2011; 39:1-13.
48. Viollet B, Andreelli F. AMP-activated protein kinase and metabolic control. Handb Exp Pharmacol. 2011; 203:303-330.
49. Carling D, Mayer FV, Sanders MJ, Gamblin SJ. AMP-activated protein kinase: nature's energy sensor. Nat Chem Biol 2011; 7:512-518.
50. Anisimov VN. Metformin for aging and cancer prevention. Aging 2010;2:760-74.
51. Xie Y, Wang Y, Yu L, Hu Q, Ji L, Zhang Y, Liao Q. Metformin promotes progesterone receptor expression via inhibition of mammalian target or rapamycin (mTOR) in endometrial cancer cells. J Ster Biochem Mol Biol 2010; Dec 17 Epub.
52. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005;310:1642-1646.
53. Jalving M, Gietema JA, Lefrandt JD, De Jong S, Reyners AKL, Gans ROB, de Vries EGE. Metformin: taking away the candy for cancer? Eur J Cancer 2010; 46:2369-2380.
54. Ouyang J, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase. J Biol Chem 2011;286:1-11.
55. Hou X, Song J, Li X-N, Zhang L, Wang XL, Chen L, Shen YH. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010;396:199-205.
56. Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, Zabezhinski MA, Anikin IV, Karkach AS, Romanyukha AA. Metformin extents life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors. Cell Cycle 2010;9:188-197.
57. Darzynkiewicz Z, Traganos F, Zhao H, Halicka HD, Skommer J, Wlodkowic D. Analysis of individual molecular events of DNA damage response by flow and image-assisted cytometry. Methods Cell Biol 2011;103:115-148.
58. Huang X, Tanaka T, Kurose A, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation on Ser-139 in cells untreated by genotoxic agents is cell-cycle phase specific and attenuated by scavenging reactive oxygen species. Int J Oncol 2006;29:495-501.
59. Rothe G, Klouche M. Phagocyte functions. Methods Cell Biol 2004;75:679-708.
60. Graham GG, Punt J, Arora M, Day RO Doogue MP, Duong JK, Furlong JR, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011;50:81-98.
61. Piwkowska A, Rogacka D, Jankowski M, Dominiczak MH, Stepinski JK, Angielski S. Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochem Biophys Res Commun 2010; 393:268-273.
62. Ouslimani, N.; Peynet, J.; Bonnefont-Rousselot, D.; Therond, P.; Legrand, A.; Beaudeux, J. L. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 2005;54:829-834.
63. Kane DA, Andersen EJ, Price III JW, Woodlief TL, Lin C-T, Bikman BT, Cortright RN, Neufer PD. Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radical Biol Med 2010;49:1082-1087.
64. Piro S, Rabuazzo AM, Renis M, Purello F. Effects of metformin on oxidative stress, adenine nucleotides balance and glucose-induced insulin release impaired by chronic FFA exposure in rat pancreatic islets. J Endocrinol Invest 2011 Jul 12 (Epub).
65. Bellin, C, de Wiza DH, Wiernsperger NF, Rosen P. Generation of reactive oxygen species by endothelial and smooth muscle cells: Influence of hyperglycemia and metformin. Horm Metab Res 2006;38:732-739.
66. Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Hohl H, Waldhansl W, Furnassin C. Thiazolidinediones, like metformin, inhibit respiratory complex I. A common mechanism contributing to their antidiabetic action. Diabetes 2004;53:1052-1059.
67. Drose S, Hanley PJ, Brandt U. Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and II. Biochim Biophys Acta 2009;1790:558-565.
68. Cleaver JA, Feeney L, Revet I. Phosphorylated H2Ax is not an unambiguous marker of DNA double strand breaks. Cell Cycle 2011;10:3223-3224.
69. Burhans WC, Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res 2007;33:7545-7556.
70. Bartkova J, Hamerlik P, Stockhausen MT, Ehrman J, Hlobikova A, Laursen H, Kalita O, Kolar Z, Paulsen HS, Broholm H, Lukas J, Bartek J. Replication stress and oxidative damage contributes to aberrant constitutive activation of DNA damage signaling in human gliomas. Oncogene 2010;29:5095-5102.
71. Zhao H, Halicka HD, Jorgensen E, Traganos F, Darzynkiewicz Z. New biomarkers probing the depth of cell senescence assessed by laser scanning cytometry. Cytometry A, 2010, 77A, 999-1007.
72. Vazquez-Martin A, Oliveras-Ferraros C, Cufi S, Martin-Castillo B, Menendez Ja. Metformin activates an Ataxia Telangiectasia Mutated (ATM)/Chk2-regulated DNA damage-like response. Cell Cycle 2011;10:1499-1501.
73. Nilsson S, Huelsenbeck J, Fritz G. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. Cancer Lett 2011;304:60-69.
74. Smart DJ, Ahmedi KP, Harvey JS, Lynch AM. Genotoxicity screening via the γH2AX by flow assay. Mutat Res 2011;71:21-31
75. Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms. Cytometry A 2007; 71A:125-131.
76. Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: Principles and applications. Meth Molec Biol. 2006; 319:165-192.